表紙:ゲノムベース医薬品の中国市場
市場調査レポート
商品コード
332740

ゲノムベース医薬品の中国市場

Genome-Based Drug Markets in China

出版日: | 発行: Asia Market Information & Development Co. | ページ情報: 英文 240 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
ゲノムベース医薬品の中国市場
出版日: 2023年06月13日
発行: Asia Market Information & Development Co.
ページ情報: 英文 240 Pages
納期: 即納可能 即納可能とは
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、中国のゲノムベース医薬品 (Genome-Based Drug) 市場の現状と将来予測(過去5~10年間の実績値および今後5~10年間の予測値)を分析し、全体的なビジネス環境や、製品別の市場動向とその見通し、市場参入戦略、関係企業一覧などの情報を取りまとめてお届けいたします。

第1章 イントロダクション

  • 分析範囲および手法
  • エグゼクティブサマリー

第2章 ビジネス環境

  • 経済情勢
    • 主な経済指標
    • 工業生産
    • 人口および労働力
    • 直接投資
    • 対外貿易
  • 金融・税務規制
    • 銀行システムと規制
    • 外国為替
    • 税制と関税

第3章 ゲノムベース医薬品産業の評価

  • ゲノムベース医薬品産業の構造
  • 市場規模
  • 市場成長促進要因
  • 主要メーカーの生産拠点・生産量
  • 主要メーカーの市場シェア
  • 人件費
  • 潜在的な参入企業
  • 主な外資系企業
  • 技術開発

第4章 ゲノムベースの医薬品の販売量とその予測

  • 概要
  • ゲノムベースの薬品の売上高とその予測
    • サイトカイン剤
    • ペプチドホルモン剤
    • 血栓溶解薬
    • 消炎酵素剤
    • 水溶性レセプター
    • 接着分子
    • 核酸薬
    • その他のゲノムベース医薬品
  • ゲノムベース医薬品の輸出入
  • 価格動向

第5章 ゲノムベース医薬品市場の展望

  • ゲノムベース医薬品市場の展望:概要
  • 政府の規制
  • 医療保険産業の概要
  • 消費者支出動向
  • 人口統計動向
  • 医療産業の動向
  • 病院および病床数
  • ゲノムベース医薬品の売上高:地域別
    • 東部
    • 北部
    • 中部
    • 南部
    • 西部

第6章 マーケティング戦略

  • 中国の流通制度
    • 中国の流通システム
    • ゲノムベース医薬品の流通チャネル
    • 交通・貨物輸送インフラ
    • 通信
  • 中国の市場参入
    • ライセンス契約
    • フランチャイジング
    • eコマース
    • 商社と現地代理店
    • 代表事務所と中国現地法人
    • 独資企業

第7章 ゲノムベース医薬品メーカーの一覧

  • ゲノムベース医薬品メーカーのプロファイル
  • 流通業者および商社
  • 研究機関および業界団体

図表一覧

図表

LIST OF TABLES

I. INTRODUCTION

  • Economic Outlook Summary
  • Genome-Based Drug Supply and Demand Summary

II. BUSINESS ENVIRONMENT

  • Key Economic Indicators
  • Industrial Output
  • Population and Labor Force Trends
  • Foreign Investment and Loans
  • Foreign Trade
  • Key Commodity Exports from China
  • China's Exports to its Leading Trade Partners
  • Key Commodity Imports into China
  • China's Imports from Its Leading Trade Partners

III. GENOME-BASED DRUG INDUSTRY ASSESSMENTS

  • Major Producer Facility Locations
  • Major Genome-Based Drug Producer Output
  • Market Share of Key Producers
  • Major Foreign Investments

IV. GENOME-BASED DRUG SALES VOLUMES AND FORECASTS

  • Overview
  • Genome-Based Drug Sales Volumes and forecasts (Yuan)
  • Cytokines Drug
  • Peptide Hormones Drug
  • Thrombolytic Agents
  • Enzyme Drug
  • Soluble Recepter
  • Adhesion Molecule
  • Nucleic Acid Drug
  • Other Genome-Based Drug
  • Genome-Based Drug Imports and Exports
  • Pricing Trends

V. GENOME-BASED DRUG Y MARKET OUTLOOKS

  • Total Genome-Based Drug Consumption by Market
  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Genome-Based Drug Sales by Region
  • Northeast
  • North
  • Southeast
  • Central
  • Southwest
  • Northwest

LIST OF CHARTS

I. INTRODUCTION

  • Economic Outlook Summary
  • Genome-Based Drug Supply and Demand Summary

II. BUSINESS ENVIRONMENT

  • Key Economic Indicators
  • Industrial Output
  • Population and Labor Force Trends
  • Foreign Investment and Loans
  • Foreign Trade
  • Key Commodity Exports from China
  • China's Exports to its Leading Trade Partners
  • Key Commodity Imports into China
  • China's Imports from Its Leading Trade Partners

III. GENOME-BASED DRUG INDUSTRY ASSESSMENTS

  • Major Producer Facility Locations
  • Major Genome-Based Drug Producer Output
  • Market Share of Key Producers
  • Major Foreign Investments

IV. GENOME-BASED DRUG SALES VOLUMES AND FORECASTS

  • Overview
  • Genome-Based Drug Sales Volumes and forecasts (Yuan)
  • Cytokines Drug
  • Peptide Hormones Drug
  • Thrombolytic Agents
  • Enzyme Drug
  • Soluble Recepter
  • Adhesion Molecule
  • Nucleic Acid Drug
  • Other Genome-Based Drug
  • Genome-Based Drug Imports and Exports
  • Pricing Trends

V. GENOME-BASED DRUG Y MARKET OUTLOOKS

  • Total Genome-Based Drug Consumption by Market
  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Genome-Based Drug Sales by Region
  • Northeast
  • North
  • Southeast
  • Central
  • Southwest
  • Northwest
目次
Product Code: 916

China's demand for Genome-Based Drug has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2012, 2017 and 2022) and long-term forecasts through 2027 and 2032 are presented. Major producers in China are profiled.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments' industry bureaus, industry publications, and our in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.

Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous fast-growing markets for imports and business opportunities for companies around the world. If you want to expand your business or sell your products in China, our research reports provide the insights and projections into Chinese markets necessary for you to do so.

TABLE OF CONTENTS

I. INTRODUCTION

  • Report Scope and Methodology
  • Executive Summary

II. BUSINESS ENVIRONMENT

  • Economic Outlook
  • Key Economic Indicators
  • Industrial Output
  • Population and Labor
  • Foreign Investment
  • Foreign Trade
  • Financial and Tax Regulations
  • Banking System and Regulations
  • Foreign Exchange
  • Taxes, Tariff and Custom Duties

III. GENOME-BASED DRUG INDUSTRY ASSESSMENTS

  • Genome-Based Drug Industry Structure
  • Market Size
  • Market Growth Drivers
  • Major Producer Facility Locations and Output
  • Market Share of Key Producers
  • Labor Costs
  • Potential Entrants
  • Major Foreign Investments
  • Technology Development

IV. GENOME-BASED DRUG SALES VOLUMES AND FORECASTS

  • Overview
  • Genome-Based Drug Sales Volumes and Forecasts (Yuan)
  • Cytokines Drug
  • Peptide Hormones Drug
  • Thrombolytic Agents
  • Enzyme Drug
  • Soluble Recepter
  • Adhesion Molecule
  • Nucleic Acid Drug
  • Other Genome-Based Drug
  • Genome-Based Drug Imports and Exports
  • Pricing Trends

V. GENOME-BASED DRUG MARKET OUTLOOKS

  • Genome-Based Drug Markets Outlook Overview
  • Government Regulations
  • Health Care Insurance Industry Overview
  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Genome-Based Drug Sales by Region
  • East
  • North
  • Central
  • South
  • West

VI. MARKETING STRATEGIES

  • Distribution System in China
  • China's Distribution System
  • Genome-Based Drug Distribution Channels
  • Transportation and Freight Infrastructure
  • Communications
  • China's Market Entry
  • Licensing
  • Franchising
  • E-commerce
  • Trading Companies and Local Agents
  • Representative Offices and Chinese Subsidiaries
  • Wholly Foreign Owned Enterprises

VII. GENOME-BASED DRUG PRODUCER DIRECTORY

  • Genome-Based Drug Producer Profiles
  • Distributors and Trading Companies
  • Research Institutions and Associations